EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Granulocytes and mast cells in AllergoOncology—Bridging allergy to cancer: An EAACI position paper

Mariona Pascal iD, Heather J Bax iD, Christoph Bergmann iD, Rodolfo Bianchini iD, Mariana Castells iD, Jitesh Chauhan iD, Leticia De Las Vecillas iD, Karin Hartmann iD, Elena Izquierdo Álvarez iD, Uta Jappe iD, Teodorikez-Wilfox Jimenez-Rodriguez iD, Edward Knol iD und 7 weitere

Allergy · 2024

DOI: 10.1111/all.16246 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Allergy, 2024. Verfasst von Mariona Pascal und 18 weiteren Autor:innen. Beteiligte Einrichtung: Immunology Department, CDB, Hospital Clínic de Barcelona; Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, B…. Hauptthemen laut MEDLINE: Mast Cells, Neoplasms, Hypersensitivity, Granulocytes. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 228 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medical Research Council, Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Derived from the myeloid lineage, granulocytes, including basophils, eosinophils, and neutrophils, along with mast cells, play important, often disparate, roles across the allergic disease spectrum. While these cells and their mediators are commonly associated with allergic inflammation, they also exhibit several functions either promoting or restricting tumor growth. In this Position Paper we discuss common granulocyte and mast cell features relating to immunomodulatory functions in allergy and in cancer. We highlight key mechanisms which may inform cancer treatment and propose pertinent areas for future research. We suggest areas where understanding the communication between granulocytes, mast cells, and the tumor microenvironment, will be crucial for identifying immune mechanisms that may be harnessed to counteract tumor development. For example, a comprehensive understanding of allergic and immune factors driving distinct neutrophil states and those mechanisms that link mast cells with immunotherapy resistance, might enable targeted manipulation of specific subpopulations, leading to precision immunotherapy in cancer. We recommend specific areas of investigation in AllergoOncology and knowledge exchange across disease contexts to uncover pertinent reciprocal functions in allergy and cancer and allow therapeutic manipulation of these powerful cell populations. These will help address the unmet needs in stratifying and managing patients with allergic diseases and cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mast CellsNeoplasmsHypersensitivityGranulocytesHumansTumor MicroenvironmentAnimalsDisease Susceptibility

Stichwörter der Autor:innen

AllergoOncologyallergybasophilscancereosinophilsgranulocytesmast cellsneutrophils

Autor:innen und Institutionen

  • Immunology Department, CDB, Hospital Clínic de Barcelona; Institut d'Investigació Biomèdica August Pi i Sunyer (IDIBAPS), Universitat de Barcelona, Barcelona, Spain.
  • Department of Medicine, Universitat de Barcelona, Barcelona, Spain.
  • RETICS Asma, reacciones adversas y alérgicas (ARADYAL) and RICORS Red De Enfermedades Inflamatorias (REI), Instituto de Salud Carlos III (ISCIII), Madrid, Spain.
  • St. John's Institute of Dermatology, School of Basic & Medical Biosciences & KHP Centre for Translational Medicine, King's College London, London, UK.
  • Department of Otorhinolaryngology, RKM740 Interdisciplinary Clinics, Düsseldorf, Germany.
  • Institute of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University Vienna, Vienna, Austria.

ORCID-Profile: Mariona Pascal, Heather J Bax, Christoph Bergmann, Rodolfo Bianchini, Mariana Castells, Jitesh Chauhan, Leticia De Las Vecillas, Karin Hartmann, Elena Izquierdo Álvarez, Uta Jappe, Teodorikez-Wilfox Jimenez-Rodriguez, Edward Knol, Francesca Levi-Schaffer, Cristobalina Mayorga, Aurélie Poli, Frank Redegeld, Alexandra F Santos, Erika Jensen-Jarolim, Sophia N Karagiannis

Förderung

  • Medical Research Council
  • Cancer Research UK

Zitieren

APA

Pascal, M., Bax, H. J., Bergmann, C., Bianchini, R., Castells, M., Chauhan, J., De Las Vecillas, L., Hartmann, K., Álvarez, E. I., Jappe, U., Jimenez-Rodriguez, T. W., Knol, E., Levi-Schaffer, F., Mayorga, C., Poli, A., Redegeld, F., Santos, A. F., Jensen-Jarolim, E., & Karagiannis, S. N. (2024). Granulocytes and mast cells in AllergoOncology—Bridging allergy to cancer: An EAACI position paper. Allergy. https://doi.org/10.1111/all.16246

Vancouver

Pascal M, Bax HJ, Bergmann C, Bianchini R, Castells M, Chauhan J, et al. Granulocytes and mast cells in AllergoOncology—Bridging allergy to cancer: An EAACI position paper. Allergy. 2024. doi:10.1111/all.16246

BibTeX
@article{Pascal2024,
  author = {Pascal, Mariona and Bax, Heather J and Bergmann, Christoph and Bianchini, Rodolfo and Castells, Mariana and Chauhan, Jitesh and De Las Vecillas, Leticia and Hartmann, Karin and Álvarez, Elena Izquierdo and Jappe, Uta and Jimenez-Rodriguez, Teodorikez-Wilfox and Knol, Edward and Levi-Schaffer, Francesca and Mayorga, Cristobalina and Poli, Aurélie and Redegeld, Frank and Santos, Alexandra F and Jensen-Jarolim, Erika and Karagiannis, Sophia N},
  title = {Granulocytes and mast cells in AllergoOncology—Bridging allergy to cancer: An EAACI position paper},
  journal = {Allergy},
  year = {2024},
  doi = {10.1111/all.16246}
}
Kostenlos starten →